Form 8-K - Current report:
SEC Accession No. 0001641172-25-020843
Filing Date
2025-07-24
Accepted
2025-07-24 16:30:25
Documents
14
Period of Report
2025-07-19
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 43007
2 EX-16.1 ex16-1.htm EX-16.1 7052
3 GRAPHIC ex16-1_001.jpg GRAPHIC 17152
  Complete submission text file 0001641172-25-020843.txt   244536

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE glsi-20250719.xsd EX-101.SCH 3053
5 XBRL LABEL FILE glsi-20250719_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE glsi-20250719_pre.xml EX-101.PRE 22384
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3800
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

EIN.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39555 | Film No.: 251147377
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)